Tonix Pharmaceuticals Holding (TNXP) - Uzoq muddatli qarzning kapitalga koeffitsiyenti

Tonix Pharmaceuticals Holding - TNXP emitenti grafik logotipi

GURU.Markets platformasida Tonix Pharmaceuticals (TNXP) kotirovkalarining vizual ko'rinishi PTSD va fibromialgiya terapiyasi uchun Tonmya dori vositasini tijoratlashtirishga kelajakdagi daromadlari bog'liq bo'lgan kompaniyaning qarz yuklamasini baholash imkonini beradi. Ushbu ko'rsatkich 0.00 darajasida turibdi. Biznes qiymatining o'sishi dori vositalarining yakuniy sinovlari natijalari va xarajatlarning kamayishiga bog'liq. Shu bilan birga, firma o'zining ishlab chiqarish korxonalariga ega emasligi sababli, uning ekologik izi minimal darajada.

Tonix Pharma (TNXP): Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022dan 31.10.2026gacha

Tonix Pharmaceuticals (TNXP) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va konsensus maqsadli narx:
Kotirovkalar grafigi Tonix Pharma|TNXP - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Tonix Pharmaceuticals Holding Corp.|TNXP - Korxona qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Tonix Pharmaceuticals|TNXP - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati tonixpharma.com|TNXP - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Tonix Pharmaceuticals|TNXP - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati tonixpharma.com|TNXP - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Tonix Pharmaceuticals Holding Corp.|TNXP - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz Tonix Pharmaceuticals|Oraliq likvidlik koeffitsiyenti tonixpharma.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
TNXP - Sof foyda
Kompaniyaning umumiy tahlili:Tonix Pharma - TNXP
Tonix Pharmaceuticals brend mahsuloti

Tonix Pharmaceuticals (TNXP) tomonidan amalga oshirilayotgan restrukturizatsiya va resurslarning klinik sinovlarning yakuniy bosqichlariga konsentratsiyasi sharoitida, qarz yuklamasini boshqarish ushbu biotexnologiya firmasi uchun hayotiy muhim omilga aylanmoqda. Ushbu ko'rsatkich bir yildan ortiq muddatli majburiyatlarni sof kapital bilan bog'laydi, bu esa uzoq muddatli qarz kapitalining kapitalga nisbatini orqali moliyaviy barqarorlikni baholash va narxlarning tez-tez uchraydigan tebranishlari davrida kapital yetishmasligi risklarini aniqlash imkonini beradi.

Raqobatdosh kompaniyalar tahlili

Haleon PLC - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati KVUE|VRNA (Verona Pharma Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati MENS (Jyong Biotech Ltd)|Uzoq muddatli qarzning kapitalga nisbati ligand.com LGND|AMRX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti PRGO (Perrigo Company PLC)|Alvotech Corp (ALVO) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Liquidia Inc.|GLPG (Galapagos NV) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati anipharmaceuticals.com|Uzoq muddatli qarzning o'z kapitaliga nisbati MNKD (MannKind)|AMPH (Amphastar Pharmaceuticals Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Pacira PCRX|ARS Corp (SPRY) - Uzoq muddatli majburiyatlarning kapitalga nisbati|TBPH: Uzoq muddatli qarzning o'z kapitaliga nisbati|aquestive.com - Uzoq muddatli kreditlarning kapitalga nisbati|SCPH: Uzoq muddatli qarzning kapitalga nisbati|Tectonic Therapeutic - Uzoq muddatli qarzning kapitalga koeffitsiyenti|SXTC (SXT Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Eupraxia Pharma EPRX|Uzoq muddatli qarzning o'z kapitaliga nisbati BioHarvest Sciences (BHST)|EXOZ (invizyne.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Oramed Pharmaceuticals Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati ENTX (Entera Bio Ltd)|HYFT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati ABVC BioPharma, Inc|Cumberland Pharmaceuticals (CPIX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi QNTM|FGEN (FibroGen) - Uzoq muddatli qarzning kapitalga nisbati|Telomir Pharmaceuticals Inc (TELO) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati RANI (Rani Therapeutics)|synergychc.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Rallybio - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti LEXX|PULM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati PTHL|APM: Uzoq muddatli qarzning kapitalga nisbati|Lyra Therapeutics Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|IBO (Impact BioMedical Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati TNF Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati cbdMD, Inc. (YCBD)|PRFX (PainReform Ltd) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Altamira Therapeutics Ltd. CYTO|LIPO - Uzoq muddatli qarzning o'z kapitaliga nisbati|OptiNose, Inc. - Uzoq muddatli qarzning kapitalga nisbati|PIRS - Uzoq muddatli qarzning kapitalga nisbati|PROC: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Petros Pharmaceuticals Inc|QLI (Qilian International Holding Group Limited) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati ACELYRIN Inc. SLRN|Uzoq muddatli qarzning o'z kapitaliga nisbati TFFP (TFF Pharmaceuticals)